Caring Brands (CABR) Non-Current Debt (2025)
Caring Brands (CABR) posted quarterly Non-Current Debt of $58650.0 for Q4 2025, up 3048.15% quarter-over-quarter from $1863.0 in Q3 2025.
Caring Brands (CABR) Non-Current Debt (2025) Analysis & Trends
Caring Brands' Non-Current Debt history runs 1 years deep, the most recent figure standing at $58650.0 for Q4 2025.
- In Q4 2025, Non-Current Debt changed N/A year-over-year to $58650.0; the TTM figure through Dec 2025 stood at $58650.0 (changed N/A YoY), while the FY2025 annual figure was $58650.0, changed N/A from the prior year.
- Non-Current Debt for Q4 2025 stood at $58650.0, up from $1863.0 in the prior quarter.
- The five-year high for Non-Current Debt was $58650.0 in Q4 2025, with the low at $1863.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 130.00 Mn |
| 10 | Caring Brands | 11.69 Mn | 9.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58,650.00 |
| Sep 30, 2025 | 1,863.00 |